TY - JOUR AU - Pavlidis, N. AU - Pentheroudakis, G. PY - 2012 DA - 2012// TI - Cancer of unknown primary site JO - Lancet. VL - 379 UR - https://doi.org/10.1016/S0140-6736(11)61178-1 DO - 10.1016/S0140-6736(11)61178-1 ID - Pavlidis2012 ER - TY - JOUR AU - Varadhachary, G. R. AU - Raber, M. N. PY - 2014 DA - 2014// TI - Cancer of unknown primary site JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMra1303917 DO - 10.1056/NEJMra1303917 ID - Varadhachary2014 ER - TY - JOUR AU - Tsimberidou, A. M. AU - Wen, S. AU - Hong, D. S. AU - Wheler, J. J. AU - Falchook, G. S. AU - Fu, S. PY - 2014 DA - 2014// TI - Personalized medicine for patients with advanced cancer in the phase I program at MD Anderson: validation and landmark analyses JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-0603 DO - 10.1158/1078-0432.CCR-14-0603 ID - Tsimberidou2014 ER - TY - JOUR AU - Kou, T. AU - Kanai, M. AU - Matsumoto, S. AU - Okuno, Y. AU - Muto, M. PY - 2016 DA - 2016// TI - The possibility of clinical sequencing in the management of cancer JO - Jpn J Clin Oncol VL - 46 UR - https://doi.org/10.1093/jjco/hyw018 DO - 10.1093/jjco/hyw018 ID - Kou2016 ER - TY - JOUR AU - Wheler, J. J. AU - Janku, F. AU - Naing, A. AU - Li, Y. AU - Stephen, B. AU - Zinner, R. PY - 2016 DA - 2016// TI - Cancer therapy directed by comprehensive genomic profiling: a single center study JO - Cancer Res VL - 76 UR - https://doi.org/10.1158/0008-5472.CAN-15-3043 DO - 10.1158/0008-5472.CAN-15-3043 ID - Wheler2016 ER - TY - JOUR AU - Shigematsu, H. AU - Lin, L. AU - Takahashi, T. AU - Nomura, M. AU - Suzuki, M. AU - Wistuba, I. I. PY - 2005 DA - 2005// TI - Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji055 DO - 10.1093/jnci/dji055 ID - Shigematsu2005 ER - TY - JOUR AU - Maemondo, M. AU - Inoue, A. AU - Kobayashi, K. AU - Sugawara, S. AU - Oizumi, S. AU - Isobe, H. PY - 2010 DA - 2010// TI - Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0909530 DO - 10.1056/NEJMoa0909530 ID - Maemondo2010 ER - TY - JOUR AU - Mok, T. S. AU - Wu, Y. L. AU - Ahn, M. J. AU - Garassino, M. C. AU - Kim, H. R. AU - Ramalingam, S. S. PY - 2017 DA - 2017// TI - Osimertinib or platinum-Pemetrexed in EGFR T790M-positive lung Cancer JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1612674 DO - 10.1056/NEJMoa1612674 ID - Mok2017 ER - TY - JOUR AU - Hemminki, K. AU - Bevier, M. AU - Hemminki, A. AU - Sundquist, J. PY - 2012 DA - 2012// TI - Survival in cancer of unknown primary site: population-based analysis by site and histology JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr536 DO - 10.1093/annonc/mdr536 ID - Hemminki2012 ER - TY - JOUR AU - Petrakis, D. AU - Pentheroudakis, G. AU - Voulgaris, E. AU - Pavlidis, N. PY - 2013 DA - 2013// TI - Prognostication in cancer of unknown primary (CUP): development of a prognostic algorithm in 311 cases and review of the literature JO - Cancer Treat Rev VL - 39 UR - https://doi.org/10.1016/j.ctrv.2013.03.001 DO - 10.1016/j.ctrv.2013.03.001 ID - Petrakis2013 ER - TY - JOUR AU - Pao, W. AU - Ladanyi, M. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-1387 DO - 10.1158/1078-0432.CCR-07-1387 ID - Pao2007 ER - TY - BOOK PY - 2017 DA - 2017// TI - SSED document ID - ref12 ER - TY - BOOK PY - 2017 DA - 2017// TI - SSED document ID - ref13 ER - TY - JOUR AU - Lopez-Chavez, A. AU - Thomas, A. AU - Rajan, A. AU - Raffeld, M. AU - Morrow, B. AU - Kelly, R. PY - 2015 DA - 2015// TI - Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.58.2007 DO - 10.1200/JCO.2014.58.2007 ID - Lopez-Chavez2015 ER - TY - JOUR AU - Kondo, T. AU - Ezzat, S. AU - Asa, S. L. PY - 2006 DA - 2006// TI - Pathogenetic mechanisms in thyroid follicular-cell neoplasia JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1836 DO - 10.1038/nrc1836 ID - Kondo2006 ER - TY - JOUR AU - Landa, I. AU - Ibrahimpasic, T. AU - Boucai, L. AU - Sinha, R. AU - Knauf, J. A. AU - Shah, R. H. PY - 2016 DA - 2016// TI - Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers JO - J Clin Invest VL - 126 UR - https://doi.org/10.1172/JCI85271 DO - 10.1172/JCI85271 ID - Landa2016 ER - TY - JOUR AU - Mitsudomi, T. AU - Morita, S. AU - Yatabe, Y. AU - Negoro, S. AU - Okamoto, I. AU - Tsurutani, J. PY - 2010 DA - 2010// TI - Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(09)70364-X DO - 10.1016/S1470-2045(09)70364-X ID - Mitsudomi2010 ER - TY - JOUR AU - Briasoulis, E. AU - Kalofonos, H. AU - Bafaloukos, D. AU - Samantas, E. AU - Fountzilas, G. AU - Xiros, N. PY - 2000 DA - 2000// TI - Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic cooperative oncology group study JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.17.3101 DO - 10.1200/JCO.2000.18.17.3101 ID - Briasoulis2000 ER - TY - JOUR AU - Culine, S. AU - Lortholary, A. AU - Voigt, J. J. AU - Bugat, R. AU - Theodore, C. AU - Priou, F. PY - 2003 DA - 2003// TI - Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: results of a randomized phase II study--trial for the French study group on carcinomas of unknown primary (GEFCAPI 01) JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.12.104 DO - 10.1200/JCO.2003.12.104 ID - Culine2003 ER - TY - JOUR AU - Blumenthal, D. T. AU - Dvir, A. AU - Lossos, A. AU - Tzuk-Shina, T. AU - Lior, T. AU - Limon, D. PY - 2016 DA - 2016// TI - Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients JO - J Neuro-Oncol VL - 130 UR - https://doi.org/10.1007/s11060-016-2237-3 DO - 10.1007/s11060-016-2237-3 ID - Blumenthal2016 ER - TY - JOUR AU - Ross, J. S. AU - Wang, K. AU - Gay, L. AU - Otto, G. A. AU - White, E. AU - Iwanik, K. PY - 2015 DA - 2015// TI - Comprehensive genomic profiling of carcinoma of unknown primary site: new routes to targeted therapies JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2014.216 DO - 10.1001/jamaoncol.2014.216 ID - Ross2015 ER - TY - JOUR AU - Varghese, A. M. AU - Arora, A. AU - Capanu, M. AU - Camacho, N. AU - Won, H. H. AU - Zehir, A. PY - 2017 DA - 2017// TI - Clinical and molecular characterization of patients with cancer of unknown primary in the modern era JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx545 DO - 10.1093/annonc/mdx545 ID - Varghese2017 ER -